Eric Jou

7PUBLICATIONS
13CO-AUTHORS
Innate immunityMolecular targetsEndodonticsOrthopaedicsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 15, 2024
Emerging roles of type 1 innate lymphoid cells in tumour pathogenesis and cancer immunotherapy.

James Michael Verner, Harry Frederick Arbuthnott, Raghavskandhan Ramachandran

|Mar 11, 2024
Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment.

Eric Jou, Natasha Chaudhury, Fizza Nasim

|Aug 22, 2023
Prophylactic antibiotic use for infective endocarditis: a systematic review and meta-analysis.

Sue S H Lean, Eric Jou, Jamie Sin Ying Ho

|Jun 03, 2022
An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis.

Eric Jou, Noe Rodriguez-Rodriguez, Ana-Carolina F Ferreira

|Jan 15, 2022
A retrospective analysis of the definitive management of open talus fractures at a major trauma centre, comparing ORIF to FUSION: cohort study and audit of BOAST 4 guidelines.

Andrew Kailin Zhou, Eric Jou, Reece Patel

Pageof 2